
1. bioorg med chem lett. 2007 may 15;17(10):2858-62. epub 2007 feb 25.

pyrazolo[1,5-a]pyridine antiherpetics: effects c3 substituent antiviral
activity.

johns ba(1), gudmundsson ks, allen sh.

author information: 
(1)department medicinal chemistry, infectious diseases cedd, glaxosmithkline
research & development, five moore drive, research triangle park, nc 27709-3398, 
usa. brian.a.johns@gsk.com

a recently disclosed series pyrazolo[1,5-a]pyridine inhibitors herpes virus
replication closely examined herein effects c3 substituent on
antiviral activity. significant changes activity observed alterations
of heteroatom basicity orientation group c3. results in
combination previous studies served elaborate minimal
pharmacophore required potency novel series antiviral agents.
during course studies, several novel synthetic approaches were
developed described.

doi: 10.1016/j.bmcl.2007.02.058 
pmid: 17350256  [indexed medline]

